found that in approximately 90% of ccRCC cases, the FGFR2 subtype switches from the normal epithelial “IIIb” subtype to the mesenchymal “IIIc” subtype, which is kidney-specific, as it is rarely observed in other cancers. Here, FGFR2 is linked to nonpapillary renal cell carcinoma.